TEMPO.CO, Jakarta - State-run pharmacy Bio Farma to distribute Sinovac's Covid-19 vaccine this month. The Food and Drug monitoring Agency (BPOM) has issued the vaccine's emergency use authorization (EUA). The company planned to distribute 7.5 doses of vaccine in the first phase.
"Our target is in line with the timeline we've set with the Health Ministry, and 7.5 million doses of [Covid-19] vaccine are ready for distribution," said Bio Farma CEO, Honesti Basyir, in a press conference with BPOM, Tuesday, Feb. 16.
This vaccine is intended for the second Covid-19 vaccination program targeting the elderlies and public service workers. The first phase of covid vaccination used the imported Sinovac vaccines from China, while the second phase uses vaccines produced by Bio Farma. The Indonesian pharmaceutical firm produced the Covid-19 vaccine by using the raw material from Sinovac.
The bulk vaccine imported from China has arrived in Indonesia in two stages; 15 million doses in January 12, and 11 million doses in February 2.
The amount of bulk Covid-19 vaccine import agreed with Sinovac is around 140 million doses, which will be sent gradually. Bio Farma, Honesti said, assures to produce until 250 million doses of vaccine in a year.